Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRISM-POrTAL: Liquid Biopsy in Community Hospitals
NCT05283044Recruiting
- Sponsor
- Gustave Roussy
- Start
- Jun 2022
- Primary completion
- Nov 2028
- Countries
- 3
01
Overview
Open-label, single-arm trial, sponsored by Gustave Roussy. Primary endpoint: Proportion of patients for whom ctDNA sequencing is performed at 72 months. Started Jun 2022; status: recruiting.
Beyond the preview
Go deeper on NCT05283044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05283044.